Logo
Logo

About Naproxen Sodium API

Product
  • Therapeutic CategoryPain Management

  • CAS Number

    26159-34-2

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF

Mechanism of Action

Naproxen has analgesic, anti-inflammatory, and antipyretic properties.

The mechanism of action of NAPRELAN, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2).

Naproxen sodium is a potent inhibitor of prostaglandin synthesis in vitro. Naproxen sodium concentrations reached during therapy have produced in vivo effects. Prostaglandins sensitize afferent nerves and potentiate the action of bradykinin in inducing pain in animal models. Prostaglandins are mediators of inflammation. Because naproxen sodium is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues.

Indication

NAPRELAN is a nonsteroidal anti-inflammatory drug indicated for the treatment of:

  • Rheumatoid arthritis (RA)
  • Osteoarthritis (OA)
  • Ankylosing spondylitis (AS)
  • Tendinitis, bursitis
  • Acute gout
  • Primary dysmenorrhea (PD)
  • The relief of mild to moderate pain

Related APIs

萘普生

Pain Management

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.